{"Symbol": "DXCM", "AssetType": "Common Stock", "Name": "DexCom Inc", "Description": "DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.", "CIK": "1093557", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS", "Address": "6340 SEQUENCE DRIVE, SAN DIEGO, CA, US", "OfficialSite": "https://www.dexcom.com/global", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "26976279000", "EBITDA": "817700000", "PERatio": "46.71", "PEGRatio": "1.016", "BookValue": "5.38", "DividendPerShare": "None", "DividendYield": "None", "EPS": "1.42", "RevenuePerShareTTM": "10.25", "ProfitMargin": "0.143", "OperatingMarginTTM": "0.17", "ReturnOnAssetsTTM": "0.0588", "ReturnOnEquityTTM": "0.276", "RevenueTTM": "4033000000", "GrossProfitTTM": "2438200000", "DilutedEPSTTM": "1.42", "QuarterlyEarningsGrowthYOY": "-0.391", "QuarterlyRevenueGrowthYOY": "0.076", "AnalystTargetPrice": "99.12", "AnalystRatingStrongBuy": "5", "AnalystRatingBuy": "17", "AnalystRatingHold": "3", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "46.71", "ForwardPE": "32.79", "PriceToSalesRatioTTM": "6.69", "PriceToBookRatio": "12.33", "EVToRevenue": "6.43", "EVToEBITDA": "27.42", "Beta": "1.504", "52WeekHigh": "139.24", "52WeekLow": "57.52", "50DayMovingAverage": "75.85", "200DayMovingAverage": "77.93", "SharesOutstanding": "392107000", "DividendDate": "None", "ExDividendDate": "None"}